Mohammed Mohialdeen, MD
Nephrology · Kansas City, MONPI 1841643210
Payments from drug & device makers
Across 14 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calliditas Therapeutics US Inc.$95
- Kerecis Limited$39
- Novartis$31
- Johnson & Johnson$30
- GSK$22
- Otsuka America Pharmaceutical, Inc.$20
- plus $78 from 5 others
What the payments were for
- Food & beverage$316100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $95 |
| Kerecis Limited | 1 | $39 |
| Novartis | 1 | $31 |
| Johnson & Johnson | 2 | $30 |
| GSK | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $20 |
| Akebia Therapeutics Inc | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $6 |
How this compares
$316 in reported general payments places this provider in the 30th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeltassaPatiromer Calcium Sorbitex | 12 | $8,787 |
| Midodrine Hcl | 12 | $2,273 |
| Sevelamer Carbonate | 24 | $1,998 |
| Torsemide | 76 | $1,728 |
| Potassium Citrate ErPotassium Citrate | 12 | $1,327 |
| Potassium Chloride | 27 | $599 |
| Tamsulosin Hcl | 24 | $426 |
| Amlodipine Besylate | 64 | $330 |
| Carvedilol | 33 | $321 |
| Losartan Potassium | 41 | $306 |
| Lisinopril | 26 | $289 |
| Furosemide | 54 | $288 |
| Chlorthalidone | 14 | $261 |
| Famotidine | 14 | $251 |
| Esomeprazole Magnesium | 12 | $187 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Ahmed AwadKansas City$12.4M
- Kelly AlfordKansas City$58K
- Tarek DarwishKansas City$52K
- Archana GoelKansas City$49K
- Richard CaplingKansas City$31K
- Thomas WiegmannKansas City$25K
- Jignesh ShahKansas City$7K
- Adnan KhanKansas City$7K
- Robert GolderKansas City$5K
- Benjamin HumphreysSaint Louis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.